Is Philip Morris a medical marijuana supporter?
Added on 20 January 2025
In a press release that went mostly unnoticed, the company announced this week a collaboration with Avicanna, a Canadian biopharmaceutical firm specializing in cannabinoid-based medicine. This partnership aims to advance medical cannabis research and improve accessibility in Canada. By leveraging Avicanna’s expertise and its MyMedi.ca platform, PMI continues its measured pivot toward health and wellness.
More news